BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9846274)

  • 1. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
    Ishikane T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
    Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
    Szczepanik AM; Wilmot CA
    Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
    Sumiyoshi T; Ichikawa J; Meltzer HY
    Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT
    Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
    Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
    Zhao C; Li M
    Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of spinal 5-HT1A receptor activation and 5-HT2A/2C receptor desensitization by chronic haloperidol.
    Gajendiran M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1449-55. PubMed ID: 17688988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
    Zhao C; Li M
    Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
    Kusumi I; Takahashi Y; Suzuki K; Kameda K; Koyama T
    J Neural Transm (Vienna); 2000; 107(3):295-302. PubMed ID: 10821438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.